[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP1305018A4 - Method and compositions for prevention and/or treatment of diabetes and glucose modulation - Google Patents

Method and compositions for prevention and/or treatment of diabetes and glucose modulation

Info

Publication number
EP1305018A4
EP1305018A4 EP00952402A EP00952402A EP1305018A4 EP 1305018 A4 EP1305018 A4 EP 1305018A4 EP 00952402 A EP00952402 A EP 00952402A EP 00952402 A EP00952402 A EP 00952402A EP 1305018 A4 EP1305018 A4 EP 1305018A4
Authority
EP
European Patent Office
Prior art keywords
diabetes
prevention
compositions
treatment
glucose modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00952402A
Other languages
German (de)
French (fr)
Other versions
EP1305018A1 (en
Inventor
Michael Menard
Susie Rockway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaNutrients Inc
Original Assignee
PharmaNutrients Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmaNutrients Inc filed Critical PharmaNutrients Inc
Publication of EP1305018A1 publication Critical patent/EP1305018A1/en
Publication of EP1305018A4 publication Critical patent/EP1305018A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EP00952402A 2000-08-02 2000-08-02 Method and compositions for prevention and/or treatment of diabetes and glucose modulation Withdrawn EP1305018A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/021050 WO2002009693A1 (en) 2000-08-02 2000-08-02 Method and compositions for prevention and/or treatment of diabetes and glucose modulation

Publications (2)

Publication Number Publication Date
EP1305018A1 EP1305018A1 (en) 2003-05-02
EP1305018A4 true EP1305018A4 (en) 2006-08-30

Family

ID=21741654

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00952402A Withdrawn EP1305018A4 (en) 2000-08-02 2000-08-02 Method and compositions for prevention and/or treatment of diabetes and glucose modulation

Country Status (4)

Country Link
EP (1) EP1305018A4 (en)
JP (1) JP2004505042A (en)
AU (1) AU2000265109A1 (en)
WO (1) WO2002009693A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE271406T1 (en) 2000-09-21 2004-08-15 Nutrition 21 Inc CHROME-CONTAINING COMPOSITION FOR TREATING DIABETES, IMPROVING INSULIN SENSITIVITY AND REDUCING HYPERGLYCEMIA, HYPERCHOLESTEROLEMIA AND BODY FAT PERCENTAGE
EP1302114A3 (en) * 2001-10-16 2004-01-14 Loders Croklaan B.V. Mixtures for stimulating glucose up-take
JP4757190B2 (en) * 2004-03-01 2011-08-24 ファルマフロンティア株式会社 Pharmaceutical composition used for lowering blood glucose level
US7666447B2 (en) 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
CN101505609B (en) 2006-08-11 2013-07-17 花王株式会社 Fat or oil composition
US8809560B2 (en) 2011-05-17 2014-08-19 Board Of Trustees Of The University Of Arkansas Trans-, trans-conjugated linoleic acid compositions and use thereof
ES2395529B1 (en) 2011-06-08 2014-04-11 Pri, S.A. SYNERGIC COMBINATION FOR THE TREATMENT OF MELLITUS DIABETES TYPE 2.
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9062276B2 (en) 2012-12-03 2015-06-23 Board Of Trustees Of The University Of Arkansas Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis
CN103190611A (en) * 2013-03-17 2013-07-10 王伟 Chrysanthemum capsules with blood sugar reducing function and preparation method thereof
WO2015031089A1 (en) * 2013-08-26 2015-03-05 Liu Charles H Nutraceutical combination for prevention and treatment of type 2 diabetes
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
JP6989262B2 (en) 2014-10-27 2022-01-05 アセコー インコーポレイテッド Subcutaneous outpatient management
US9886556B2 (en) 2015-08-20 2018-02-06 Aseko, Inc. Diabetes management therapy advisor
CN107243043A (en) * 2017-08-17 2017-10-13 刘明州 A kind of Chinese medicine treated diabetes and control its complication to occur

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265772A2 (en) * 1986-10-27 1988-05-04 Abbott Laboratories Liquid nutritional formula for glucose intolerance
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
WO1998042211A2 (en) * 1997-03-24 1998-10-01 Progressive Research Labs Nutritional supplements for improving glucose metabolism
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
US6063820A (en) * 1997-03-20 2000-05-16 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Medical food for diabetics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2252874T3 (en) * 1997-12-12 2006-05-16 Purdue Research Foundation USE OF CONJUGATED LINOLEIC ACID FOR TREATMENT OF MELLITUS TYPE II DIABETES.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265772A2 (en) * 1986-10-27 1988-05-04 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US6063820A (en) * 1997-03-20 2000-05-16 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Medical food for diabetics
WO1998042211A2 (en) * 1997-03-24 1998-10-01 Progressive Research Labs Nutritional supplements for improving glucose metabolism
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MCCARTY M F ET AL: "Rationales for micronutrient supplementation in diabetes.", MEDICAL HYPOTHESES. FEB 1984, vol. 13, no. 2, February 1984 (1984-02-01), pages 139 - 151, XP009069813, ISSN: 0306-9877 *
MCCARTY M F: "TOWARD A WHOLLY NUTRITIONAL THERAPY FOR TYPE 2 DIABETES", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH, US, vol. 54, no. 3, March 2000 (2000-03-01), pages 483 - 487, XP001105930, ISSN: 0306-9877 *
PELTON R: "SUPPLEMENTS CAN FORESTALL DIABETES COMPLICATIONS WITH 64 MILLION DIABETES-RELATED SCRIPTS DISPENSED EACH YEAR, OPPORTUNITIES FOR NUTRITIONAL COUNSELING ABOUND", AMERICAN DRUGGIST, vol. 216, no. 8, 1999, pages 52 - 53, XP000908773, ISSN: 0190-5279 *
See also references of WO0209693A1 *

Also Published As

Publication number Publication date
WO2002009693A1 (en) 2002-02-07
JP2004505042A (en) 2004-02-19
EP1305018A1 (en) 2003-05-02
AU2000265109A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
EP1305018A4 (en) Method and compositions for prevention and/or treatment of diabetes and glucose modulation
PT1231887E (en) Method and composition for the treatment of scars
IL157327A0 (en) Composition and methods for modulation of vascular structure and/or function
MXPA01009415A (en) Ascorbic acid composition and method for treatment of aging or damaged skin.
PL364995A1 (en) Method for the treatment or prevention of flavivirus
AUPR638101A0 (en) Composition and method for treatment of disease
GB0110288D0 (en) Composition and treatment method
MXPA03006043A (en) Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis.
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
IL161073A0 (en) Composition and method for treating diabetes
AU1794801A (en) Method for treatment and prevention of physiological shock
PL348049A1 (en) Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications
EP1089731A4 (en) Compositions and methods for treating elevated blood cholesterol
GB2343844B (en) Composition and method for treatment of hypertrophic skin accumlations and their prevention
AU2003231279A8 (en) Prevention and treatment of type 2 diabetes
GB2399500B (en) Composition and method for treatment of wounds
AU2001273759A1 (en) Essential oils and chemically related species for the treatment of increased bone resorption
AU2002230509A1 (en) Devices and methods for treating low blood sugar levels
HUP0300043A3 (en) Method and composition for the treatment of pain
EP1089732A4 (en) Compositions and methods for treating elevated blood cholesterol
AU2002322862A1 (en) Methods and compositions for diagnosis and treatment of vascular conditions
GB9928681D0 (en) Method and composition for treatment or prophylaxis of diabetes
AU2001247546A1 (en) Method and composition for treatment and prevention of alopecia
EP1161242A4 (en) Composition and method for treating diabetes
AU2001281747A1 (en) Composition and method for the treatment or prevention of hiv infection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030128

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20060728

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/10 20060101ALI20060725BHEP

Ipc: A61K 33/24 20060101ALI20060725BHEP

Ipc: A61K 31/201 20060101AFI20060725BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061027